Wave Life Sciences
110 hedge funds and large institutions have $1.14B invested in Wave Life Sciences in 2019 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 56 increasing their positions, 15 reducing their positions, and 11 closing their positions.
273% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 15
164% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 11
20% more funds holding
Funds holding: 92 → 110 (+18)
11% more capital invested
Capital invested by funds: $1.03B → $1.14B (+$117M)
3.19% more ownership
Funds ownership: 82.8% → 85.99% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
40% less call options, than puts
Call options by funds: $5.38M | Put options by funds: $8.95M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$52M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$36.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$32.5M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$24.1M |
| 5 |
RI
RTW Investments
New York
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$26.4M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
-$17.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.7M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$9.84M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$6.62M |
WVE Hedge Fund Activity: Q1 2019 in Review
110 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2019, worth a combined $1.14B — up 11% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new WVE positions and 11 closed out — a net gain of 18 holders — while 56 added to existing stakes and 15 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $52M. The largest seller was Boxer Capital, cutting an estimated $26.4M.
- 110 institutional investors held Wave Life Sciences (WVE) as of Q1 2019, up from 92 in Q4 2018.
- Funds reported $1.14B of Wave Life Sciences stock for Q1 2019, up 11% quarter-over-quarter.
- 29 funds opened new Wave Life Sciences positions in Q1 2019 and 11 closed out, a net change of +18 holders.
- The largest Wave Life Sciences buyer in Q1 2019 was Janus Henderson Group, an estimated $52M added.
- The largest Wave Life Sciences seller in Q1 2019 was Boxer Capital, an estimated $26.4M sold.
Based on aggregated 13F filings for Q1 2019.